According to a report by the European News Agency on December 26th, the Official Gazette of Spain (BOE) has published and registered the collective agreement of British American Tobacco (BAT). The agreement will be valid from July 1, 2023 to March 31, 2026. It stipulates that employees will receive a 2% wage increase from April 1, 2022, to be distributed retroactively.
According to BOE records, a disposable amount equivalent to 0.35% of the base salary will be paid in the same remuneration statement, retroactive to April 2022. This amount is non-consolidatable.
In addition, during the duration of this new agreement, a 1% increase in basic salary for employees in D-level positions and above has been specified from April 1, 2023, to March 31, 2026. As for employees in B and C-level positions, their salary adjustments will be based on the date of their eligibility to participate in the Annual Salary Review (ASR) system. These adjustments will take effect on April 1 of the following year.
Therefore, despite reaching a negotiated salary adjustment, it has also been agreed within the duration of this contract to implement a new salary review system called Annual Salary Review (ASR) in addition to the basic salary increase schedule. This system will operate within the company globally and will be effective from the date of signing this agreement until its expiration.
As a result of this new supplementary salary review system, a new subsidy called the "Annual Performance Evaluation Subsidy" has been established, which will be applicable from April 1, 2022 to March 31, 2026.
Regarding remote work, this multinational company's new collective contract states that remote work only applies to office staff and specifies that employees can work remotely for two days per week throughout the year. However, in July, under exceptional circumstances, remote work can be extended to three days, and in August, employees can work remotely for the entire workweek, which consists of five days.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
